Protocol

Metabolic-axis research peptides

GLP-1 / GIP / glucagon incretin work, GHRH analogs, NNMT inhibitors — the molecules most often cited in pre-clinical metabolic studies.

Curated for this protocol

Peptide

$55 per vial

$495 per 10-vial kit

Peptide

$95 per vial

$855 per 10-vial kit

Peptide

$155 per vial

$1,395 per 10-vial kit

Peptide

$80 per vial

$720 per 10-vial kit

Peptide

$120 per vial

$1,080 per 10-vial kit

Peptide

$65 per vial

$585 per 10-vial kit

What molecules dominate the metabolic-axis literature?
Retatrutide as the triple agonist (GLP-1 / GIP / glucagon), Tirzepatide as the dual GLP-1 / GIP agonist, Tesamorelin as the GHRH analog, and 5-Amino-1MQ as the NNMT inhibitor. All are RUO.
Why is Retatrutide offered in multiple potency tiers?
Pre-clinical dose-response work benefits from a graded potency range. The 5/10/20/40 mg presentations cover the standard cohort sizes researchers ask for.
How do these ship?
Lyophilized vials ship from our Canadian fulfillment facility (2–4 business days across Canada). Each lot carries a lot-specific certificate of analysis.
Is this catalog for human use?
No. All products are sold strictly for laboratory research use only and are not intended to diagnose, treat, cure, or prevent any disease.